Mazen M. Dimachkie 2022. Optimizing chronic inflammatory demyelinating polyneuropathy care with subcutaneous immunoglobulin: The Polyneuropathy and Treatment with Hizentra Open-Label Extension (PATH OLE) study and beyond. RRNMF Neuromuscular Journal. 3, 2 (Jun. 2022), 13–26. DOI:https://doi.org/10.17161/rrnmf.v3i2.16304.